CRESTOR Safety Questions, CRESTOR Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CRESTOR. Our extensive database of CRESTOR adverse events and CRESTOR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CRESTOR

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




CRESTOR Safety Reports

Total CRESTOR reports: 2640.
CRESTOR FDA safety alerts: 2004 2005 .
Reported deaths: 48    Reported hospitalizations: 402.
Take CRESTOR Side Effects Survey or Share Your CRESTOR Story. CRESTOR Usage.

Showing 1-75 of 2640 Next >

Physician from UNITED STATES reported CRESTOR problem on Mar 09, 2006. Male patient, 51 years of age, was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: alopecia, madarosis, sexual dysfunction. CRESTOR dosage: 10 MG QD PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, weighting 165.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: faeces discoloured. CRESTOR dosage: 10 MG QD PO. During the same period patient was treated with VITAMINS. Patient recovered.

Physician from UNITED STATES reported CRESTOR problem on Mar 07, 2006. Male patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, high density lipoprotein decreased. CRESTOR dosage: 5 MG PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2006. Male patient, 72 years of age, weighting 186.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: dry eye, eye haemorrhage, eye irritation, muscle spasms, vision blurred, vitreous floaters. CRESTOR dosage: 5 MG DAILY PO. During the same period patient was treated with CENTRUM, VITAMIN CAP, OCUVITE, XALATAN, IBUPROFEN, CHONDROITIN W. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 08, 2006. Female patient, 74 years of age, weighting 146.5 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: weight increased. CRESTOR dosage: 10 MG PO. During the same period patient was treated with GEMFIBROZIL, DIOVAN, LEVOXYL. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: anorectal disorder. CRESTOR dosage: 5 MG PO. During the same period patient was treated with INDERAL, TOPAMAX. Patient recovered.

Physician from UNITED STATES reported CRESTOR problem on June 22, 2006. Female patient, 69 years of age, weighting 200.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: alopecia, flank pain, influenza like illness, muscle tightness, myalgia. CRESTOR dosage: 10 MG QD PO. During the same period patient was treated with LEVOXYL, ATENOLOL, FLU SHOT. Patient recovered.

CRESTOR problem was reported by a Physician from UNITED STATES on Mar 30, 2006. Female patient, 62 years of age, weighting 160.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, constipation, dry mouth, epistaxis, flatulence, nasal dryness, swollen tongue. CRESTOR dosage: unknown. During the same period patient was treated with FOSAMAX, CATAPRES, VITAMIN CAP, ASPIRIN, CALCIUM SUPPLEMENTS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on May 12, 2006. Female patient, 68 years of age, weighting 150.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, dry mouth. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with LORAZEPAM, ATENOLOL. Patient recovered.

CRESTOR problem was reported by a Physician from UNITED STATES on Mar 08, 2006. Female patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, high density lipoprotein decreased. CRESTOR dosage: 5 MG PO. Patient recovered.

Physician from UNITED STATES reported CRESTOR problem on Mar 06, 2006. Female patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased. CRESTOR dosage: 10 MG QD PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2004. Female patient, 58 years of age, weighting 200.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: chest pain, constipation, haematochezia, haemorrhoids, hypoaesthesia, myalgia, pain in extremity. CRESTOR dosage: 20 MG QD PO. During the same period patient was treated with RANITIDINE, ASPIRIN, THYROID MEDICINE, QUININE, VITAMIN, CALCIUM, ASCORBIC ACID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on May 22, 2004. Female patient, 78 years of age, weighting 134.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: gait disturbance, malaise, musculoskeletal stiffness, myalgia, pain, vertigo. CRESTOR dosage: unknown. During the same period patient was treated with TOPROL, NEXIUM, NORVASC. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2006. Female patient, 61 years of age, weighting 175.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: cough, dysphonia. CRESTOR dosage: 20 MG PO. During the same period patient was treated with VERAPAMIL, PREMARIN, AMILORIDE AND HYDROCHLOROTHIAZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 10, 2006. Male patient, 61 years of age, weighting 145.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: back pain, renal pain. CRESTOR dosage: 10 MG PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2006. Male patient was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: myalgia, sensation of heaviness. CRESTOR dosage: 20 MG QD PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 08, 2006. Female patient, 58 years of age, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: muscle disorder. CRESTOR dosage: 5 MG PO. Patient recovered.

CRESTOR problem was reported by a Physician from UNITED STATES on Apr 03, 2006. Female patient, 65 years of age, weighting 130.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anal discomfort, fatigue, muscle spasms, tension. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with AVANDIA, ATENOLOL, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 10, 2006. Female patient was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: vision blurred. CRESTOR dosage: 5 MG PO. During the same period patient was treated with LYRICA. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2006. Male patient, 76 years of age, weighting 160.0 lb, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, nausea, pyrexia. CRESTOR dosage: 20 MG QD PO. During the same period patient was treated with PLAVIX, ASPIRIN, SYNTHROID, PRILOSEC, FOSAMAX. Patient recovered.

Physician from UNITED STATES reported CRESTOR problem on Apr 10, 2006. Female patient, 55 years of age, weighting 257.0 lb, was diagnosed with hyperlipidaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: alopecia. CRESTOR dosage: 10 MG QD PO. Patient recovered.

CRESTOR problem was reported by a Physician from UNITED STATES on Mar 28, 2006. Female patient, 81 years of age, weighting 125.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state. CRESTOR dosage: 10 MG PO. During the same period patient was treated with ACTINAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 10, 2006. Female patient, 62 years of age, weighting 130.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anxiety, back pain, depression, dizziness, erythema, headache, hypoaesthesia, nausea. CRESTOR dosage: 10 MG PO. During the same period patient was treated with POTASSIUM ACETATE, ESTROGENIC SUBSTANCE, ZETIA. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2006. Female patient, 70 years of age, weighting 163.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, hypertension. CRESTOR dosage: 10 MG PO. During the same period patient was treated with CARTIA, THYROID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 13, 2006. Female patient, 45 years of age, weighting 153.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, muscle spasms. CRESTOR dosage: unknown. During the same period patient was treated with GLIPIZIDE. Patient recovered.

CRESTOR problem was reported by a Physician from UNITED STATES on Mar 13, 2006. Female patient, 72 years of age, weighting 189.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, high density lipoprotein increased, low density lipoprotein increased. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with ATENOLOL W, PREMPRO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 13, 2006. Male patient, 69 years of age, weighting 265.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: pain. CRESTOR dosage: 10 MG PO. During the same period patient was treated with NORVASC, TYLENOL. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2006. Female patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: breath sounds abnormal, chills, dyskinesia, feeling hot, headache. CRESTOR dosage: 10 MG PO. Patient recovered.

Pharmacist from UNITED STATES reported CRESTOR problem on Mar 13, 2005. Male patient, 44 years of age, was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: asthenopia, pain in extremity, visual acuity reduced. CRESTOR dosage: 5 MG QD PO. Patient recovered.

CRESTOR problem was reported by a Physician from UNITED STATES on Mar 10, 2006. Male patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, mobility decreased, myalgia. CRESTOR dosage: 20 MG PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 06, 2006. Female patient, 53 years of age, weighting 165.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: back pain, muscle spasms, muscle strain, myalgia. CRESTOR dosage: unknown. During the same period patient was treated with VERAPAMIL. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2006. Male patient, 59 years of age, weighting 180.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: pain, weight loss poor. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with ZETIA, DIOVAN. Patient recovered.

Physician from UNITED STATES reported CRESTOR problem on Apr 17, 2006. Female patient, 63 years of age, weighting 130.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, back pain, chest discomfort, choking, multiple sclerosis, muscle spasms, muscular weakness, musculoskeletal chest pain. CRESTOR dosage: 10 MG PO. During the same period patient was treated with COREG, PREVACID, BONIVA, LORAZEPAM, AMBIEN, VITAMINS. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2006. Female patient, 85 years of age, weighting 149.0 lb, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: amnesia. CRESTOR dosage: 5 MG QD PO. During the same period patient was treated with LASIX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 06, 2006. Male patient was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal, heart rate increased. CRESTOR dosage: 10 MG PO. During the same period patient was treated with AVALIDE, SULAR. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2006. Male patient, 69 years of age, weighting 200.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, rash erythematous, urticaria. CRESTOR dosage: 5 MG PO. During the same period patient was treated with ATENOLOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 06, 2006. Female patient, 82 years of age, weighting 140.0 lb, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: insomnia, nervousness, pruritus. CRESTOR dosage: 10 MG QD PO. During the same period patient was treated with BENICAR, VERAPAMIL, PREVACID, WARFARIN. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2006. Female patient, 69 years of age, weighting 193.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: dry mouth, dysgeusia. CRESTOR dosage: 10 MG QD PO. During the same period patient was treated with EVISTA, ALLEVA, CELEBREX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 06, 2006. Male patient, 69 years of age, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, insomnia, mental status changes. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with COZAAR, NEXIUM. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2006. Female patient, 62 years of age, weighting 180.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: low density lipoprotein increased. CRESTOR dosage: 10 MG PO. During the same period patient was treated with ATENOLOL, DIOVAN, HYDROCHLOROTHIAZIDE, PAXIL, METFORMIN, WELLBUTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 02, 2006. Female patient, 57 years of age, weighting 163.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, feeling abnormal, hyperhidrosis, pollakiuria. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with CARDIZEM, AMERON, HORMONE, NITROGLYCERIN, DIOVAN. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2006. Female patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: muscle spasms, visual acuity reduced. CRESTOR dosage: 5 MG QOD PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 02, 2006. Female patient, 77 years of age, weighting 198.2 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: headache, myalgia, photosensitivity reaction, visual acuity reduced. CRESTOR dosage: 10 MG QD PO. During the same period patient was treated with NEURONTIN, HYDROCHLOROTHIAZIDE. Patient recovered.

CRESTOR problem was reported by a Physician from UNITED STATES on Mar 31, 2006. Female patient, 64 years of age, weighting 175.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: amnesia. CRESTOR dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 02, 2006. Female patient, 63 years of age, was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: dry mouth, tongue disorder. CRESTOR dosage: 10 MG HS PO. During the same period patient was treated with TOPROL. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2006. Female patient, 45 years of age, weighting 128.0 lb, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: facial paresis, fatigue, muscular weakness, speech disorder. CRESTOR dosage: 10 MG QD TPL. During the same period patient was treated with LABETALOL, INSULIN, ASPIRIN. Patient recovered.

Physician from UNITED STATES reported CRESTOR problem on Feb 27, 2006. Male patient, 40 years of age, was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: affective disorder, weight increased. CRESTOR dosage: 10 MG DAILY PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Female patient, 78 years of age, weighting 125.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: rhinorrhoea. CRESTOR dosage: 10 MG PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 14, 2006. Male patient, 74 years of age, weighting 220.0 lb, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. CRESTOR dosage: 5 MG PO. During the same period patient was treated with PLAVIX, TOPROL, ALTACE, OMEPRAZOLE, GLYBURIDE. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Male patient, 53 years of age, weighting 230.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: arthralgia, myalgia, nipple pain. CRESTOR dosage: 5 MG QD PO. During the same period patient was treated with OXYCONTIN, DIAZEPAM, TOPROL, TEMAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Feb 27, 2006. Male patient was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: anal discomfort, constipation. CRESTOR dosage: 5 MG QD PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2006. Female patient, 71 years of age, weighting 132.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: alopecia, skin burning sensation. CRESTOR dosage: 10 MG PO. During the same period patient was treated with COZAAR, PRILOSEC, DICYCLOMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 14, 2006. Female patient, weighting 148.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: alopecia. CRESTOR dosage: unknown. During the same period patient was treated with DIOVAN HCT, ATENOLOL. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2006. Male patient, 47 years of age, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: arthralgia, asthenia, back pain, headache, irritability. CRESTOR dosage: 10 MG PO. During the same period patient was treated with ATENOLOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 14, 2006. Male patient, 58 years of age, weighting 195.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling jittery. CRESTOR dosage: 10 MG PO. During the same period patient was treated with ALLOPURINOL, ACETYLSALICYLIC ACID SRT, ANTACID. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Female patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: tooth abscess. CRESTOR dosage: 10 MG PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Feb 27, 2006. Male patient, 63 years of age, weighting 170.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: weight increased. CRESTOR dosage: 10 MG PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Male patient, 64 years of age, weighting 165.0 lb, was diagnosed with blood triglycerides increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: eye disorder, flatulence. CRESTOR dosage: 10 MG PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Feb 24, 2006. Male patient, 47 years of age, weighting 185.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction. CRESTOR dosage: 10 MG PO. During the same period patient was treated with VERAPAMIL. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2006. Female patient, 80 years of age, weighting 161.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, faeces discoloured. CRESTOR dosage: 5 MG PO. During the same period patient was treated with NEXIUM, BISOPROLOL, ZETIA, ASPIRIN, PLETAL, VITAMINS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Feb 24, 2006. Male patient was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: therapeutic response unexpected. CRESTOR dosage: 10 MG PO. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2006. Male patient, 64 years of age, weighting 171.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: fatigue, feeling cold, pyrexia. CRESTOR dosage: 10 MG PO. During the same period patient was treated with ASPIRIN, PHENYLEPHRINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Feb 23, 2006. Female patient, 72 years of age, weighting 150.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: dry mouth, tongue dry. CRESTOR dosage: 10 MG PO. During the same period patient was treated with ATENOLOL, VITAMINS. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2006. Female patient, 79 years of age, weighting 150.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, arthralgia, constipation, eructation, flatulence, nausea. CRESTOR dosage: 10 MG PO. During the same period patient was treated with NORVASC, ASPIRIN, MONOPRIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 21, 2006. Female patient, 55 years of age, weighting 175.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: furuncle. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with KLONOPIN, PROZAC, ADVAIR DISKUS, ALBUTEROL, TRAZODONE. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Female patient, 62 years of age, was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: acne. CRESTOR dosage: 10 MG DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 21, 2006. Male patient, 81 years of age, weighting 250.0 lb, was diagnosed with arterial occlusive disease, oedema peripheral and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, nausea. CRESTOR dosage: 20 MG PO. During the same period patient was treated with PLAVIX. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Female patient, 75 years of age, weighting 120.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: eye pruritus. CRESTOR dosage: 20 MG PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 20, 2006. Female patient, 80 years of age, weighting 125.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: eye disorder, pain in extremity. CRESTOR dosage: 5 MG PO. During the same period patient was treated with CLONIDINE, SYNTHROID, ASPIRIN, ENALAPRIL MALEATE, OXYBUTYNIN, METOPROLOL SUCCINATE, CALCIUM, VITAMIN CAP. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Female patient, 76 years of age, weighting 133.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: diarrhoea. CRESTOR dosage: 5 MG PO. During the same period patient was treated with DETROL, ZANTAC, GEMFIBROZIL, ACCOLATE, EYE DROPS, NASONEX. Patient recovered.

Physician from UNITED STATES reported CRESTOR problem on Apr 28, 2006. Male patient, 70 years of age, weighting 140.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: neuralgia, urticaria. CRESTOR dosage: 5 MG PO. During the same period patient was treated with BENADRYL, CLONAZEPAM, OMEPRAZOLE. Patient recovered.

CRESTOR problem was reported by a Health Professional from UNITED STATES on Mar 20, 2006. Male patient, 55 years of age, weighting 154.0 lb, was diagnosed with high density lipoprotein increased, low density lipoprotein increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody increased. CRESTOR dosage: 10 MG DAILY PO. During the same period patient was treated with ZETIA, FLAXSEED OIL, FISH OIL, CLONIDINE, ENALAPRIL MALEATE, NORVASC, COREG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 20, 2006. Female patient, 97 years of age, weighting 180.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: alopecia. CRESTOR dosage: 5 MG DAILY PO. During the same period patient was treated with AVAPRO, TORSEMIDE, ROGAINE. Patient recovered.

CRESTOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Female patient, 67 years of age, weighting 150.0 lb, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: formication, paraesthesia. CRESTOR dosage: 10 MG PO. During the same period patient was treated with ACTOS, LAMICTAL, PERCOCET, ADVIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CRESTOR problem on Mar 20, 2006. Female patient, 54 years of age, weighting 160.0 lb, was diagnosed with blood cholesterol increased and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: cystitis, urine odour abnormal. CRESTOR dosage: 5 MG PO. Patient recovered.

Showing 1-75 of 2640 Next >

Ask Our Patient Community about CRESTOR

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
Phenergan